|

Phase III clinical trial went very smoothly, vaccine could be ready by November/December – Global Times

The Global Times has tweeted the update in recent trade, although there have been zero uptakes on the headline in markets. 

Researchers around the world are racing to develop a vaccine against Covid-19, with more than 170 candidate vaccines now tracked by the World Health Organization (WHO).

In phase 3 trials, the vaccine is usually given to thousands of people to confirm its safety – including rare side effects – and effectiveness. These trials involve a control group which is given a placebo.

To date, more broadly speaking, scientists have been hoping to develop a coronavirus vaccine within 12 to 18 months.

Author

Ross J Burland

Ross J Burland, born in England, UK, is a sportsman at heart. He played Rugby and Judo for his county, Kent and the South East of England Rugby team.

More from Ross J Burland
Share:

Markets move fast. We move first.

Orange Juice Newsletter brings you expert driven insights - not headlines. Every day on your inbox.

By subscribing you agree to our Terms and conditions.

Editor's Picks

EUR/USD continues its rise as Dollar retreats on Fed action and soft data

EUR/USD advances during the North American on Thursday up 0.41% after the Fed decided to cut rates, alongside the release of weaker than expected job data in the United States. The pair trades at 1.1742 after bouncing off daily lows of 1.1682.

GBP/USD steadies at fresh near-term highs

GBP/USD is holding firmly in bullish territory heading into the tail end of the week, but Cable bidders ran into a technical resistance point at the 1.3400 handle on Thursday. The Federal Reserve delivered a third straight interest rate cut this week, bolstering broad-market risk appetite and pushing the US Dollar into the low side across the board.

Gold climbs above $4,250 as Fed rate cut weakens US Dollar

Gold price rises to seven-week highs near $4,275 during the early Asian session on Friday. The precious metal extends its upside as the US Federal Reserve’s quarter-point rate cut drags the US Dollar lower. 

Ethereum: Thomas Lee's bottom call aligns with taker buyers positioning

Ethereum buyers are beginning to regain strength following signs of recovery in Net Taker Volume on the crypto exchange Binance. The metric tracks the difference between buyers and sellers purchasing ETH using market orders. The volume has improved from a low of about -$500 million in October — which triggered heavy ETH distribution — to -$138 million. 

FOMC Summary: A split cut and a clear shift toward caution

The Federal Reserve (Fed) went ahead with a 25 basis points rate cut, taking the target range to 3.50–3.75%. But the tone around the decision mattered just as much as the move.

Solana dips as hawkish Fed cuts dampen market sentiment
Solana (SOL) price is trading below $130 at the time of writing on Thursday, after being rejected at the upper boundary of its falling wedge pattern. The broader market weakness following the Federal Reserve’s hawkish rate cut has added to downside momentum.